Fig. 8From: HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanomaEvaluation of HOPX expression and IC50s for clinical medications. (A) High HOPX expression reduces the IC50 values of some clinical drugs and combats drug resistance, (B) but the response to other drugs is unaffected in GDSC (genomics of drug sensitivity in cancer) and TCGA (The Cancer Genome Atlas) databaseBack to article page